ROLLOVER STUDY; MULTICENTRE, PHASE III, OPEN-LABEL STUDY TO FURTHER EVALUATE THE SAFETY AND EFFICACY OF PALOVAROTENE CAPSULES IN MALE AND FEMALE PARTICIPANTS AGED ¿14 YEARS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP) WHO HAVE COMPLETED STUDY PVO-1A-301 OR PVO-1A-202/PVO-1A-204 AND MAY BENEFIT FROM PALOVAROTENE THERAPY

Registry ID

CLIN-60120-452

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

IPSEN PHARMA

Start date

2022-12-07

Completion date

2025-01-31

Last update

2021-12-21

Conditions

• FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (FOP)

Related clinical trials

• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF INCB000928 IN PARTICIPANTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA

View on source registry